Biotechnology Industry Immersion
Crafted for future leaders, Graduate School of Management Biotechnology Industry Immersion combines cutting-edge biotechnology insights with advanced leadership and management training. Gain a robust understanding of the dynamic forces propelling the biotech industry forward.
You’ll learn from top industry executives through live cases about:
- Growth and new developments
- Drug innovations
- Entrepreneurship
- Drug regulations
- Marketing and commercialization
Program Highlights
- Curriculum designed by both UC Davis faculty and industry executives to reflect the latest challenges in the industry
- Hands-on, problem-solving experiences each week with a team of MBA-biotech sciences student team
- Five weeks of interactive classes taught by senior executives from a select group of companies
- Group assignments in every class, examining potential solutions to management challenges
- Merit-based scholarships are available to incoming MBA admits annually.
Testimonials
“Most MBA programs leverage cases to help bring texture to business concepts, but the Immersion program brings cases to life and lets you experience them.” – David Bodimer MBA 19
“It’s a fantastic opportunity for students to get some knowledge and classroom learning about the intersection between business, academia and biotechnology.” – Christopher Murriel, OncoMed Pharmaceuticals
Advisory Board
| Member | Affiliation | Title |
|---|---|---|
| Steven Chamow | Alira Health LLC | Principal Consultant Advisory Board Chair |
| David Dodds | Dodds and Associates | Consultant |
| Cory Berkland | Washington University | Professor and Entrepreneur |
|
Travis Engleman |
Danaher | VP Business Development |
| Russ Lehrman | Alira Health LLC | Consultant and Entrepreneur |
| Niall O'Donnell | Rivervest Ventures | Venture Capitalist |
| John Selep | Agtech Innovation Alliance | Co-founder and Chairman |
| Sunita Dhar | Genentech | Executive Medical Group Director |
| Fernando Beils | Qiagen | Sr. VP, Molecular Diagnostics |
| Christian Borjesson | Beckman Coulter (Danaher) | President, Microbiology |
| Mimi Villanueva | Biora Therapeutics | Vice President PD Operations and Project Management |
Recent Executive Speakers
- Lonnie Bookbinder, Ph.D., MBA, Founder and CEO, ARIZ Precision Medicine
- Robert Bottome, Executive Director, Global Supply Chain, BioMarin Pharmaceutical, Inc.
- Seema Kantak, Ph.D., Executive Director, Biologics & Biotherapeutics, Exelixis, Inc.
- Anna Marie Tuazon, Ph.D., Manager, Regulatory Affairs, Gilead Sciences, Inc.
- Craig Shimasaki, Ph.D., MBA, President and CEO, Moleculera Labs and BioSource Consulting
- Tracy Brockman Shafizadeh, Ph.D., Director, Scientific Communications, Evolve BioSystems, Inc.
- Samara Freeman, Ph.D., Director of Regulatory Affairs and Intellectual Property, Evolve BioSystems, Inc.
- Steve Chamow, Ph.D., Principal, Chamow and Associates
- Kristen Beck, Ph.D., Staff Scientist, Research Staff Member, Industrial and Applied Genomics, IBM Research-Almaden
- Vivien Chan, Ph.D., Chief Operating Officer, Eureka Therapeutics, Inc.
Photo Gallery
Image
Image
Image
Image
